Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NICHD

Method For The Detection Of A Subdural Hematoma For Use In A Handheld Hematoma Detector And Discriminator.

  • Read more about Method For The Detection Of A Subdural Hematoma For Use In A Handheld Hematoma Detector And Discriminator.
US Application 61/286,626
Filed on 2009-12-15

Methods of Diagnosis and Treatement of Cancer Using Metaiodobenzylguanidine

  • Read more about Methods of Diagnosis and Treatement of Cancer Using Metaiodobenzylguanidine
US Application 61/260,991
Filed on 2009-11-13

Identification OfNovel Thermostable Y-Family Polymerases From Fungi.

  • Read more about Identification OfNovel Thermostable Y-Family Polymerases From Fungi.
US Application 61/289,901
Filed on 2009-12-23

Cholesterol Therapy For Autistic Spectrum Disorder

  • Read more about Cholesterol Therapy For Autistic Spectrum Disorder
US Application 61/169,775
Filed on 2009-04-16

Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes

  • Read more about Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes
US Application 61/187,263
Filed on 2009-06-15

Polarization Adapter For Colposcope

  • Read more about Polarization Adapter For Colposcope
US Application 61/242,652
Filed on 2009-09-15

Spin Echo Sequences For Diffusion Weighted Imaging of Moving Media

  • Read more about Spin Echo Sequences For Diffusion Weighted Imaging of Moving Media
US Application 61/523,108
Filed on 2011-08-12

Pyro-glutamate Serpinin (pE-Serpinin), A Novel Protection Peptide Against Oxidative Stress In Cell And A Biomarker For Inflammatory Disease

  • Read more about Pyro-glutamate Serpinin (pE-Serpinin), A Novel Protection Peptide Against Oxidative Stress In Cell And A Biomarker For Inflammatory Disease
US Application 61/172,013
Filed on 2009-04-23

Carboxypeptidase E-gammaN Biomarker For Determining Metastasis And Predicting Recurrence Of Paragangliomas And Differentiated Thyroid Carcinomas

  • Read more about Carboxypeptidase E-gammaN Biomarker For Determining Metastasis And Predicting Recurrence Of Paragangliomas And Differentiated Thyroid Carcinomas
US Application 61/161,568
Filed on 2009-03-19

A Mutlicomponent Vaccine For Malaria Providing Long-lasting Immune Responses Against Plasmodia.

  • Read more about A Mutlicomponent Vaccine For Malaria Providing Long-lasting Immune Responses Against Plasmodia.
US Application 61/112,527
Filed on 2008-11-07

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • …
  • Next page ››
  • Last page Last »
Subscribe to NICHD
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health